Premium
Is sildenafil neutral on cardiopulmonary performance in group 2 pulmonary hypertension? More details for interpretation
Author(s) -
Guazzi Marco
Publication year - 2017
Publication title -
european journal of heart failure
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.149
H-Index - 133
eISSN - 1879-0844
pISSN - 1388-9842
DOI - 10.1002/ejhf.753
Subject(s) - sildenafil , medicine , placebo , pulmonary hypertension , population , cardiology , respiratory exchange ratio , ejection fraction , respiratory minute volume , heart failure , vo2 max , heart rate , anesthesia , respiratory system , blood pressure , alternative medicine , environmental health , pathology